Theratechnologies Inc
NASDAQ:THTX

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
NASDAQ:THTX
Watchlist
Price: 3.39 USD Market Closed
Market Cap: 155.9m USD

Wall Street
Price Targets

THTX Price Targets Summary
Theratechnologies Inc

There are no price targets for THTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Theratechnologies Inc Competitors:
Price Targets
SNDX
Syndax Pharmaceuticals Inc
91% Upside
TGTX
TG Therapeutics Inc
59% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
22% Upside
BMRN
Biomarin Pharmaceutical Inc
56% Upside
1530
3SBio Inc
39% Upside
HALO
Halozyme Therapeutics Inc
7% Upside
ARGX
argenx SE
25% Upside
302440
SK Bioscience Co Ltd
18% Downside

Revenue
Forecast

Revenue Estimate
Theratechnologies Inc

For the last 12 years the compound annual growth rate for Theratechnologies Inc's revenue is 17%. The projected CAGR for the next 3 years is 6%.

17%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Theratechnologies Inc

The compound annual growth rate of Theratechnologies Inc's operating income for the next 3 years is 37%.

N/A
Past Growth
37%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Theratechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is THTX's stock price target?
Not Available

THTX doesn't have any price targets made by Wall Street professionals.

What is Theratechnologies Inc's Revenue forecast?
Projected CAGR
6%

For the last 12 years the compound annual growth rate for Theratechnologies Inc's revenue is 17%. The projected CAGR for the next 3 years is 6%.

What is Theratechnologies Inc's Operating Income forecast?
Projected CAGR
37%

The compound annual growth rate of Theratechnologies Inc's operating income for the next 3 years is 37%.

Back to Top